[CrossRef] [PubMed] [Google Scholar] Diabetes-related neurological implications and pharmacogenomics
Some side effects may be included on its warning labels
Rather than serving as a first-line treatment, it is typically considered an adjunctive therapy that may complement more established approaches, such as physical therapy, exercise modification, and other evidence-based interventions
Subjects with obesity treated with semaglutide for 12 weeks showed an average 24% reduction in energy intake over 3 meals/snacks and, similar to liraglutide, no effect on energy expenditure despite a decrease in resting metabolic rate (RMR)
This includes leaky gut, adrenal fatigue , insomnia, and heart disease
However, GLP-1 medications like Ozempic cause food to remain in the stomach for many more hours, even days